Having established that the administration of apelin to lean mice, thereby mimicking the obesity situation, led to an increased TNBC growth and brain metastases formation, we next wondered whether the apelinergic system could be a realistic therapeutic target for TNBC in obese conditions. The gene discussed is APLN; the disease is obesity disorder.